PEAK6 Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-25,752
Closed -$3.32M 4273
2017
Q4
$3.27M Buy
25,752
+23,495
+1,041% +$2.95M 0.11% 1074
2017
Q3
$265K Sell
2,257
-31,309
-93% -$2.67M 0.01% 3058
2017
Q2
$2.68M Buy
33,566
+15,366
+84% +$982K 0.12% 1118
2017
Q1
$933K Buy
18,200
+23
+0.1% +$1.06K 0.05% 1740
2016
Q4
$681K Buy
18,177
+2,185
+14% +$91.5K 0.03% 2219
2016
Q3
$1.08M Buy
15,992
+2,746
+21% +$194K 0.06% 1708
2016
Q2
$735K Buy
13,246
+9,463
+250% +$596K 0.05% 2042
2016
Q1
$237K Buy
+3,783
New +$252K 0.02% 2977
2015
Q4
Sell
-26,972
Closed -$2.17M 4695
2015
Q3
$2.17M Sell
26,972
-7,507
-22% -$834K 0.08% 1517
2015
Q2
$4.13M Buy
34,479
+5,333
+18% +$637K 0.15% 953
2015
Q1
$3.04M Buy
29,146
+9,958
+52% +$1.01M 0.13% 976
2014
Q4
$1.86M Buy
19,188
+3,739
+24% +$346K 0.07% 1390
2014
Q3
$1.21M Buy
+15,449
New +$997K 0.03% 1659

Other funds holding ALNY